Voyager Therapeutics
VYGR
VYGR
119 hedge funds and large institutions have $547M invested in Voyager Therapeutics in 2018 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 40 increasing their positions, 35 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
4% less capital invested
Capital invested by funds: $569M → $547M (-$21.6M)
5% less funds holding
Funds holding: 125 → 119 (-6)
26% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 23
Holders
119
Holding in Top 10
4
Calls
$655K
Puts
$533K
Top Buyers
| 1 | +$24.4M | |
| 2 | +$12.7M | |
| 3 | +$5.49M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$3.97M |
| 5 |
HCM
Highline Capital Management
New York
|
+$3.05M |
Top Sellers
| 1 | -$28.4M | |
| 2 | -$18M | |
| 3 | -$6.96M | |
| 4 |
Millennium Management
New York
|
-$2.88M |
| 5 |
PP
PDT Partners
New York
|
-$2.06M |